Pharmaron Beijing Co., Ltd. (300759.SZ)
CNY 23.17
(-1.49%)
CNY 23.17
(-1.49%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.6 Billion CNY | 16.48% |
| 2022 | 1.37 Billion CNY | -17.24% |
| 2021 | 1.66 Billion CNY | 41.68% |
| 2020 | 1.17 Billion CNY | 114.25% |
| 2019 | 547.19 Million CNY | 61.31% |
| 2018 | 339.22 Million CNY | 46.94% |
| 2017 | 230.85 Million CNY | 30.49% |
| 2016 | 176.91 Million CNY | 139.57% |
| 2015 | 73.84 Million CNY | 251.73% |
| 2014 | 20.99 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 308.39 Million CNY | -65.07% |
| 2024 Q1 | 230.55 Million CNY | -50.1% |
| 2024 Q2 | 882.84 Million CNY | 282.92% |
| 2023 FY | 1.6 Billion CNY | 16.48% |
| 2023 Q3 | 352.94 Million CNY | -19.39% |
| 2023 Q2 | 437.83 Million CNY | 25.72% |
| 2023 Q1 | 348.25 Million CNY | -15.78% |
| 2023 Q4 | 462.05 Million CNY | 30.92% |
| 2022 Q1 | 249.08 Million CNY | -59.89% |
| 2022 Q3 | 375.67 Million CNY | 11.69% |
| 2022 Q4 | 413.49 Million CNY | 10.07% |
| 2022 FY | 1.37 Billion CNY | -17.24% |
| 2022 Q2 | 336.34 Million CNY | 35.03% |
| 2021 Q3 | 475.22 Million CNY | 48.99% |
| 2021 Q4 | 620.96 Million CNY | 30.67% |
| 2021 Q1 | 245.87 Million CNY | -35.86% |
| 2021 FY | 1.66 Billion CNY | 41.68% |
| 2021 Q2 | 318.96 Million CNY | 29.73% |
| 2020 Q3 | 310.08 Million CNY | -17.85% |
| 2020 Q2 | 377.44 Million CNY | 271.8% |
| 2020 Q1 | 101.51 Million CNY | -53.6% |
| 2020 FY | 1.17 Billion CNY | 114.25% |
| 2020 Q4 | 383.33 Million CNY | 23.62% |
| 2019 Q4 | 218.81 Million CNY | 30.98% |
| 2019 Q3 | 167.05 Million CNY | 56.23% |
| 2019 Q2 | 106.92 Million CNY | 96.57% |
| 2019 Q1 | 54.39 Million CNY | -49.91% |
| 2019 FY | 547.19 Million CNY | 61.31% |
| 2018 Q4 | 108.59 Million CNY | 0.49% |
| 2018 FY | 339.22 Million CNY | 46.94% |
| 2018 Q3 | 108.06 Million CNY | 32.86% |
| 2018 Q2 | 81.33 Million CNY | 99.23% |
| 2018 Q1 | 40.82 Million CNY | -45.95% |
| 2017 Q4 | 75.53 Million CNY | 0.0% |
| 2017 FY | 230.85 Million CNY | 30.49% |
| 2016 FY | 176.91 Million CNY | 139.57% |
| 2015 FY | 73.84 Million CNY | 251.73% |
| 2014 FY | 20.99 Million CNY | 0.0% |